Kim E. Leitzel
Penn State Cancer Institute · 145 works · 1,357 citations · h-index 20
Top works
- Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
- Serial serum c-erbB-2 levels in patients with breast carcinoma
- Growth Factors and Wound Healing in the Hamster
- Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients
- Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
- Elevated plasma platelet-derived growth factor B-chain levels in cancer patients.
- Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization‐positive patients with metastatic breast cancer treated with trastuzumab
- Inhibition of Wound Healing by Topical Steroids
- Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR
- HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
- Elevated Bone Turnover Predicts for Bone Metastasis in Postmenopausal Breast Cancer: Results of NCIC CTG MA.14
- Elevated plasma tissue inhibitor of metalloproteinase‐1 level predicts decreased response and survival in metastatic breast cancer
- Pretreatment serum uPA and survival in patients with advanced pancreatic cancer
- Effect of osteoporosis in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27.
- Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer
- Elevated plasma tissue inhibitor of metalloproteinase‐1 levels predict decreased survival in castration‐resistant prostate cancer patients
- Enhanced tumor growth in vivo by a factor in human platelets and rat liver.
- Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans
- Serum 1-OH vitamin D (D) and prognosis of postmenopausal breast cancer (BC) patients: NCIC-CTG MA14 trial
- High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts